View Item 

Show simple item record

Comparative Risk of Impaired Glucose Metabolism Associated with Cyclosporine Versus Tacrolimus in the Late Posttransplant Period
dc.contributor.authorLuan, Fu Len_US
dc.contributor.authorZhang, H.en_US
dc.contributor.authorSchaubel, Douglas E.en_US
dc.contributor.authorMiles, C. D.en_US
dc.contributor.authorCibrik, Diane M.en_US
dc.contributor.authorNorman, Silas P.en_US
dc.contributor.authorOjo, Akinlolu O.en_US
dc.date.accessioned2010-06-01T18:35:49Z
dc.date.available2010-06-01T18:35:49Z
dc.date.issued2008-09en_US
dc.identifier.citationLuan, F. L.; Zhang, H.; Schaubel, D. E.; Miles, C. D.; Cibrik, D.; Norman, S.; Ojo, A. O. (2008). "Comparative Risk of Impaired Glucose Metabolism Associated with Cyclosporine Versus Tacrolimus in the Late Posttransplant Period." American Journal of Transplantation 8(9): 1871-1877. <http://hdl.handle.net/2027.42/71799>en_US
dc.identifier.issn1600-6135en_US
dc.identifier.issn1600-6143en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/71799
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18786231&dopt=citationen_US
dc.format.extent210327 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights© 2008 American Society of Transplantation and the American Society of Transplant Surgeonsen_US
dc.subject.otherCalcineurin Inhibitor Agentsen_US
dc.subject.otherKidney Transplantationen_US
dc.subject.otherNew Onset Diabetes Mellitusen_US
dc.titleComparative Risk of Impaired Glucose Metabolism Associated with Cyclosporine Versus Tacrolimus in the Late Posttransplant Perioden_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Biostatistics, University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationotherInternal Medicine, Division of Nephrologyen_US
dc.contributor.affiliationotherUniversity of Nebraska, Omaha, NEen_US
dc.contributor.affiliationother3914 Taubman Center, Box 0364, 1500 East Medical Center Drive, Ann Arbor, MIen_US
dc.identifier.pmid18786231en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/71799/1/j.1600-6143.2008.02328.x.pdf
dc.identifier.doi10.1111/j.1600-6143.2008.02328.xen_US
dc.identifier.sourceAmerican Journal of Transplantationen_US
dc.identifier.citedreferenceKrentz AJ, Wheeler DC. New-onset diabetes after transplantation: A threat to graft and patient survival. Lancet 2005; 365: 640 – 642.en_US
dc.identifier.citedreferenceCosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int 2002; 62: 1440 – 1446.en_US
dc.identifier.citedreferenceHjelmesaeth J, Hartmann A, Leivestad T et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006; 69: 588 – 595.en_US
dc.identifier.citedreferenceKasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178 – 185.en_US
dc.identifier.citedreferenceMiles AM, Sumrani N, Horowitz R et al. Diabetes mellitus after renal transplantation: As deleterious as non-transplant-associated diabetes? Transplantation 1998; 65: 380 – 384.en_US
dc.identifier.citedreferenceFriedman EA, Shyh TP, Beyer MM, Manis T, Butt KM. Posttransplant diabetes in kidney transplant recipients. Am J Nephrol 1985; 5: 196 – 202.en_US
dc.identifier.citedreferenceCosio FG, Kudva Y, Van Der Velde M et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005; 67: 2415 – 2421.en_US
dc.identifier.citedreferenceWilkinson A, Davidson J, Dotta F et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005; 19: 291 – 298.en_US
dc.identifier.citedreferenceAmerican Diabetes A. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2007; 30: S42 – S47.en_US
dc.identifier.citedreferenceHeisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am J Transplant 2004; 4: 583 – 595.en_US
dc.identifier.citedreferenceAraki M, Flechner SM, Ismail HR et al. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. Transplantation 2006; 81: 335 – 341.en_US
dc.identifier.citedreferencevan Hooff JP, Christiaans MH, van Duijnhoven EM. Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation 2005; 79: 1465 – 1469.en_US
dc.identifier.citedreferenceMarcen R, Morales JM, del Castillo D et al. Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years. Transplant Proc 2006; 38: 3530 – 3532.en_US
dc.identifier.citedreferenceVincenti F, Friman S, Scheuermann E et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007; 7: 1506 – 1514.en_US
dc.identifier.citedreferenceEkberg H, Tedesco-Silva H, Demirbas A et al. Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation. N Engl J Med 2007; 357: 2562 – 2575.en_US
dc.identifier.citedreferenceArtz MA, Boots JM, Ligtenberg G et al. Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile. Am J Transplant 2004; 4: 937 – 945.en_US
dc.identifier.citedreferenceLigtenberg G, Hene RJ, Blankestijn PJ, Koomans HA. Cardiovascular risk factors in renal transplant patients: Cyclosporin A versus tacrolimus. J Am Soc Nephrol 2001; 12: 368 – 373.en_US
dc.identifier.citedreferenceBaid-Agrawal S, Delmonico FL, Tolkoff-Rubin NE et al. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients. Transplantation 2004; 77: 1199 – 1202.en_US
dc.identifier.citedreferencePirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 1997; 63: 977 – 983.en_US
dc.identifier.citedreferenceMayer AD, Dmitrewski J, Squifflet JP et al. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 1997; 64: 436 – 443.en_US
dc.identifier.citedreferenceJohnson C, Ahsan N, Gonwa T et al. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. Transplantation 2000; 69: 834 – 841.en_US
dc.identifier.citedreferenceChamienia A, Biedunkiewicz B, Krol E, Debska-Slizien A, Rutkowski B. One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus. Transplant Proc 2006; 38: 81 – 85.en_US
dc.identifier.citedreferenceMarcen R, Chahin J, Alarcon A, Bravo J. Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: A prospective study. Transplant Proc 2006; 38: 2427 – 2430.en_US
dc.identifier.citedreferenceMeier M, Nitschke M, Weidtmann B et al. Slowing the progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus: A randomized controlled trial. Transplantation 2006; 81: 1035 – 1040.en_US
dc.identifier.citedreferenceBackman LA. Post-transplant diabetes mellitus: The last 10 years with tacrolimus. Nephrol Dial Transplant 2004; 19 ( Suppl 6 ): vi13 – vi16.en_US
dc.identifier.citedreferenceBolin PJS, Mulloy F, Gao L, Henning J, Bartucci A, Holman M, First J Jr, MR. Optimizing Tacrolimus Therapy in Maintenance Renal Allograft: 12 Month Results. Am J Transplant 2007; 7 ( S2 ): 207.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-6143.2008.02328.x.pdf
Size:
205.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.